Skye Bioscience, Inc. Common Stock (SKYE)

Skye Bioscience, Inc. Common Stock (SKYE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.2M; returns 1 day -4.9%, 1 week -0.6%, 1 year +6.2%.

Skye Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for obesity and other metabolic diseases. The company currently generates no revenue from product sales, as its business model is entirely centered on the research and development of its drug pipeline.

Groups SKYE belongs to

• Recent Reverse Splits
• Clinical Stage Biopharma
• Biotechnology
• Metabolic Disorders
• Weight Management
• Biopharmaceutical
• Monoclonal Antibodies
• Healthcare
• Strategic Pivot

SKYE financial model: income statement, cash flow and balance sheet